KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Non Operating Income (2016 - 2025)

Gilead Sciences' Non Operating Income history spans 17 years, with the latest figure at $349.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 1097.14% year-over-year to $349.0 million; the TTM value through Dec 2025 reached $798.0 million, up 11300.0%, while the annual FY2025 figure was $798.0 million, 13200.0% up from the prior year.
  • Non Operating Income reached $349.0 million in Q4 2025 per GILD's latest filing, down from $569.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $569.0 million in Q3 2025 to a low of -$369.0 million in Q1 2021.
  • Average Non Operating Income over 5 years is -$10.8 million, with a median of -$53.5 million recorded in 2023.
  • Peak YoY movement for Non Operating Income: soared 3030.0% in 2023, then plummeted 460.44% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $57.0 million in 2021, then plummeted by 117.54% to -$10.0 million in 2022, then skyrocketed by 3030.0% to $293.0 million in 2023, then plummeted by 111.95% to -$35.0 million in 2024, then soared by 1097.14% to $349.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Non Operating Income are $349.0 million (Q4 2025), $569.0 million (Q3 2025), and $208.0 million (Q2 2025).